Filling the Gap

News, Case Studies, Whitepapers, Articles

Filter by topic

15 May 2019

OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share

ROCHESTER, Mich.May 08, 2019 (GLOBE NEWSWIRE) OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the first quarter ended March 31, 2019. Quarterly comparisons are to the same year-ago quarter.


by OptimizeRx

Blog Subscription

Get all the latest news